Trial Profile
Randomized, Double-Blind, Double-Dummy, 5-Way Crossover Study to Evaluate the Abuse Potential of Cenobamate Relative to Alprazolam and Placebo When Administered Orally in Non-Dependent, Recreational Drug Users With Sedative Experience
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Cenobamate (Primary) ; Alprazolam
- Indications Bipolar disorders; Neuropathic pain; Partial epilepsies
- Focus Pharmacodynamics
- Sponsors SK Life Science
- 02 May 2018 New trial record